echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > In collaboration with the Institute of Nutrition and Health, a new mechanism for reprogramming to regulate liver cancer metabolism has been discovered.

    In collaboration with the Institute of Nutrition and Health, a new mechanism for reprogramming to regulate liver cancer metabolism has been discovered.

    • Last Update: 2020-07-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On July 6, 2020, the international academic journal Nature cancer published online the latest research results of Yin Huiyong, Shanghai Institute of nutrition and health, Chinese Academy of Sciences, entitled "aldolase B suppresses endothelial carcinogenesis by inhibiting G6PD and pentose phosphate pathways", The role, mechanism and clinical significance of aldolase B (aldob) in the regulation of metabolic reprogramming in hepatocellular carcinoma.metabolic abnormality is one of the important characteristics of tumor. Tumor cells will undergo a series of metabolic reprogramming to meet the needs of rapid proliferation.the Warburg effect proposed in the 1920s pointed out that even under aerobic conditions, tumor cells can produce energy and raw materials for cell proliferation by anaerobic glycolysis.therefore, the molecular mechanism and clinical significance of tumor cell metabolic reprogramming have been one of the important directions in the field of tumor research.recent studies have found that tumor cells can realize metabolic reprogramming by using gene mutation, epigenetic changes, protein-protein interaction and the interaction between metabolic enzymes and metabolites.aldolase catalyzes the cleavage of FBP in glycolysis to produce dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP), and the reverse reaction of DHAP and gap to produce FBP in gluconeogenesis.aldob was mainly expressed in liver, small intestine and kidney.previous studies have found that the expression of aldob is down-regulated in hepatocellular carcinoma and its expression is associated with prognosis. However, the molecular mechanism and clinical significance of aldob in the metabolic regulation of hepatocellular carcinoma (HCC) remain to be clarified. The incidence rate ofis the sixth place in all cancers worldwide, and the mortality rate is fourth.China is a big country of liver cancer, and more than 55% of the new cases of liver cancer are in China every year.in this study, we found that the expression of aldob was significantly down-regulated in HCC patients' tumor tissues, and glucose-6-phosphate dehydrogenase (glucose-6-phosphate dehydrogenase), a rate limiting enzyme in the pentose phosphate pathway, was found in HCC patients, The patients with low expression of aldob and high expression of G6PD had short survival time and poor prognosis, and aldob could be an independent risk factor for HCC.next, the researchers used aldob whole body or liver specific knockout mice, and used N-nitrosodiethylamine, In the HCC mice model induced by den, the tumorigenesis was significantly aggravated after aldob knockout. Compared with the adjacent tissues, the activity of G6PD and PPP metabolic flow in tumor tissues were up-regulated; the tumor formation was significantly inhibited by the supplement of aldob expression in liver specific knockout mice; the tumor formation induced by aldob deletion was inhibited by chemical inhibition of G6PD enzyme activity or down-regulation of G6PD expression at gene level.mechanism studies found that in normal hepatocytes, aldob and G6PD inhibit G6PD enzyme activity through direct protein interaction; at the same time, aldob can significantly enhance the inhibitory effect of tumor suppressor gene p53 on G6PD.in tumor cells, the down-regulation of aldob expression relieves the inhibition of G6PD, which leads to the enhancement of PPP metabolism, and provides the synthetic materials needed for rapid growth of tumor cells, as well as NADPH and glutathione (as shown in the figure).the results are supported by metabonomics and a variety of stable isotope metabolic flow data.in conclusion, this study elucidates a new molecular mechanism of cell metabolism regulation: the interaction between aldob and G6PD, two important metabolic enzymes in glycolysis and pentose phosphate pathway, regulates cell metabolism; the loss of aldob in tumor cells promotes its metabolic remodeling to promote tumor growth.this study found a new non enzyme function of aldob, and also suggested the value of the expression and interaction of aldob and G6PD in the clinical diagnosis and treatment of liver cancer. Professor Yin Huiyong and assistant researcher Tao Yongzhen of Shanghai Institute of nutrition and health, Chinese Academy of Sciences, and Cheng shuqun, director of the Third Affiliated Hospital of Naval Military Medical University, are the corresponding authors of the paper. Li Min and he Xuxiao, doctoral students of Shanghai Institute of nutrition and health, Chinese Academy of Sciences, and Dr. Guo Weixing, the Third Affiliated Hospital of Naval Military Medical University, are the co authors of the paper. this work has been strongly supported by Li dangsheng and Ding Jianping, researcher Li Yu, Shanghai Institute of nutrition and health, Chinese Academy of Sciences, and Professor Lin Shengcai and Lin Shuhai of Xiamen University. this project is supported by the National Natural Science Foundation of China, the Ministry of science and technology and the Chinese Academy of Sciences. . Glycolysis metabolic enzyme Aldob regulates the molecular mechanism of liver cancer metabolic remodeling. Link: the official account was hosted by the microbiological resources and big data center of the Institute of Microbiology, Chinese Academy of Sciences. In 2019, Wen Wen TOP101. reversed the type 2 diabetes, Daniel wrote again: type 2 diabetes is a simple disease, reducing weight or reversing the disease. 2. Just now, science released ten scientific breakthroughs in 2019! 3. Science! Broccoli awakens anti-tumor gene! Chinese medical doctor's letter to his father published in Chinese by lancet! Your "honey", my "arsenic..." 6. Drinking, especially those who blush, may face a higher risk of dementia. 7. Nature weighs heavily! The first creature to completely synthesize and completely change the DNA code was born. 8. This is not a big hazelnut! Science has published a new oral insulin, or will replace the traditional injection 9. Science to prevent baldness: start from never losing hair... 10. Can changing sperm speed affect the sex of offspring?
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.